Skip to main content
Clinical Trials/NCT01617499
NCT01617499
Completed
Not Applicable

Physical Activity for Campus Employees

Washington University School of Medicine1 site in 1 country141 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
Washington University School of Medicine
Enrollment
141
Locations
1
Primary Endpoint
Daily Step Count (determined by pedometer)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this pilot study is to evaluate the effects of a worksite wellness program on physical activity and cardiovascular disease risk factors among university employees. The investigators hypothesize that the proposed worksite wellness program will be effective for increasing daily physical activity and improving one or more cardiovascular disease risk factors among university employees.

Detailed Description

Cardiovascular disease (CVD) persists as the leading cause of mortality in the United States and accounts for 17 percent of the nation's overall health expenditures. Although the mortality rate of CVD has declined in recent years, the burden of disease remains high. Currently, 1 in 3 Americans has some form of CVD. Additionally, according to a recent policy statement published by the American Heart Association (AHA), 40% of the population is projected to have some form of CVD by 2030. Furthermore, the AHA has projected that the cost to treat CVD will triple by 2030. The prevalence and rising financial burden of CVD demonstrate the urgency for effective implementation of disease prevention strategies. Evidence suggesting the majority of CVD is preventable through modifiable risk factor management continues to grow. Nonetheless, difficulty controlling modifiable risk factors remains an issue for many Americans. The magnitude of this challenge is supported by a study revealing that 78% of adults are candidates for at least one CVD prevention activity. Although national organizations have published a variety of disease prevention recommendations, widespread implementation of and adherence to preventative programs remain problematic. Consequently, a large proportion of the population is not receiving or participating in prevention strategies from which they may benefit. The full potential of reducing the nation's CVD burden cannot be achieved unless interventions are implemented on a larger scale, with reduced costs, and with increased initial and continued participation. With approximately 130 million Americans currently employed, workplaces provide ideal environments for implementation of sizable, cost-effective CVD prevention programs. However, successful wellness programming remains a laborious, resource intensive challenge for employers. In 2004, a National Worksite Health Promotion Survey disclosed that less than 7% of U.S. employers offered worksite wellness programs. Furthermore, an estimated 25-30% of companies' annual medical costs are spent on employees with CVD risk factors. In the proposed study, a worksite wellness program that includes health assessments, personal health reports, and pedometer-based tracking of physical activity will be offered to university employees. Participants will not be randomized to an intervention or control group. Rather, program components will be available to all enrolled participants, and each individual may choose whether to wear a pedometer, track their step counts, attend wellness sessions, and/or complete the health assessments. There is no prescribed intervention. Wellness sessions include educational information on lifestyle behaviors to promote cardiometabolic health.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
December 2012
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • employee of Washington University in St. Louis

Exclusion Criteria

  • pregnancy

Outcomes

Primary Outcomes

Daily Step Count (determined by pedometer)

Time Frame: Baseline, week 4, and week 8

Daily step counts, as recorded by pedometers, will be self-reported by participants for 7 continuous days at 3 study time points: baseline, week 4, and week 8.

Secondary Outcomes

  • Body weight(Baseline and week 9)
  • waist circumference(Baseline and week 9)
  • Blood Pressure(Baseline and week 9)
  • Total Cholesterol(Baseline and week 9)
  • HDL Cholesterol(Baseline and week 9)
  • Participant evaluation of the wellness program(Weeks 12 - 14)
  • Dietary patterns(Baseline and week 9)
  • Perceived barriers to exercise participation(Baseline and week 9)
  • Perceived benefits of exercise(Baseline and week 9)
  • Body Mass Index (BMI)(Baseline and week 9)
  • Body Composition(Baseline and week 9)
  • Fasting plasma glucose(Baseline and week 9)
  • LDL Cholesterol(Baseline and week 9)
  • Triglycerides(Baseline and week 9)
  • Non-HDL Cholesterol(Baseline and week 9)
  • Resting heart rate(Baseline and week 9)
  • Cardiorespiratory fitness based on post-exercise recovery heart rate(Baseline and week 9)
  • Physical activity patterns(Baseline and week 9)

Study Sites (1)

Loading locations...

Similar Trials